Literature DB >> 843422

Enzyme induction and renal function in man.

E E Ohnhaus, J Martin, J Kinser, J P Colombo.   

Abstract

1. In a previous study in rats, an increased PAH clearance was found following chronic phenobarbitone administration. These results formed the basis for the present study in which fifteen healthy male volunteers were investigated and the parameters of liver microsomal enzyme activity and renal function were measured. 2. As parameters of liver microsomal enzyme activity, the antipyrine elimination in the plasma, the gamma-glutamyl-transpeptidase and the D-glucaric excretion in the urine were measured. Endogenous creatinine clearance, 51Cr-EDTA and 125I-Hippuran clearance were determined as measurements of renal function. 3. No correlation was found between any of the parameters of microsomal enzyme activity and renal function. 4. Of the fifteen volunteers, seven having a mean antipyrine half-life of 13.3 h were given antipyrine (500 mg) daily for 3 weeks. Afterwards all measurements of liver microsomal enzyme activity and renal function were repeated. The antipyrine half-life decreased to 8.5 h, while the antipyrine clearance was increased by about 56%. gamma-glutamyl-transpeptidase and D-glucaric acid were also significantly increased, while renal function remained unchanged. 5. Therefore, an increased PAH-clearance, as found in the rat, is not obtained in man following induction of liver microsomal enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 843422      PMCID: PMC1428984          DOI: 10.1111/j.1365-2125.1977.tb00663.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  [Stimulation of the renal excretion of p-aminohippuric acid by repeated application of phenobarbital].

Authors:  R Storch; H Bräunlich
Journal:  Acta Biol Med Ger       Date:  1975

2.  Fatty acid inducible cy tochrome P-454 of rat kidney cortex microsomes.

Authors:  S Jakobsson; H Thor; S Orrenius
Journal:  Biochem Biophys Res Commun       Date:  1970       Impact factor: 3.575

3.  Pharmacokinetic drug interactions.

Authors:  L F Prescott
Journal:  Lancet       Date:  1969-12-06       Impact factor: 79.321

4.  Dose-dependent enzyme induction.

Authors:  A Breckenridge; M L Orme; L Davies; S S Thorgeirsson; D S Davies
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

5.  Effective renal plasma flow: estimation from theoretical volumes of distribution of intravenously injected 131-I orthoiodohippurate.

Authors:  W N Tauxe; F T Maher; W F Taylor
Journal:  Mayo Clin Proc       Date:  1971-08       Impact factor: 7.616

6.  Urinary excretion of chlorothiazide in rats before and after phenobarbitone administration.

Authors:  E E Ohnhaus
Journal:  Experientia       Date:  1972-07-15

7.  Failure of various drugs to induce drug-metabolizing enzymes in extrahepatic tissues of the rat.

Authors:  G Feuer; J C Sosa-Lucero; G Lumb; G Moddel
Journal:  Toxicol Appl Pharmacol       Date:  1971-08       Impact factor: 4.219

8.  Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man.

Authors:  J B Whitfield; D W Moss; G Neale; M Orme; A Breckenridge
Journal:  Br Med J       Date:  1973-02-10

9.  Increased glucuronidation of bilirubin in man and rat by administration of antipyrine (phenazone).

Authors:  M L Orme; L Davies; A Breckenridge
Journal:  Clin Sci Mol Med       Date:  1974-04

10.  Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.

Authors:  R A Branch; D G Shand; G R Wilkinson; A S Nies
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

View more
  14 in total

1.  Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Authors:  E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

2.  The influence of enzyme induction on polymorphic sparteine oxidation.

Authors:  M Eichelbaum; S Mineshita; E E Ohnhaus; C Zekorn
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

3.  Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis.

Authors:  H P Hoensch; K Balzer; P Dylewizc; W Kirch; H Goebell; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man.

Authors:  E E Ohnhaus; E Gerber-Taras; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  [The pharmacokinetics of digoxin during chronic spironolacton treatment (author's transl)].

Authors:  J P Masson; O Bass; H R Baur; E E Ohnhaus
Journal:  Klin Wochenschr       Date:  1978-11-01

6.  Influence of phenobarbital treatment on cimetidine kinetics.

Authors:  A Somogyi; S Thielscher; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Pharmacokinetic interaction of antimicrobial agents with levomethadon in drug-addicted AIDS patients.

Authors:  N H Brockmeyer; L Mertins; M Goos
Journal:  Klin Wochenschr       Date:  1991-01-04

8.  Pharmacokinetics of encainide in patients with cirrhosis.

Authors:  G Wensing; H Mönig; E E Ohnhaus; H P Hoensch
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

9.  The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.

Authors:  E E Ohnhaus; W Berger; F Duckert; F Oesch
Journal:  Klin Wochenschr       Date:  1983-09-01

10.  A link between liver microsomal enzyme activity and thyroid hormone metabolism in man.

Authors:  E E Ohnhaus; H Studer
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.